Opendata, web and dolomites

HemoScreen SIGNED

Point-of-care hematology analyser based on visco-elastic focusing, digital imaging, image processing and machine learning

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HemoScreen project word cloud

Explore the words cloud of the HemoScreen project. It provides you a very rough idea of what is the project "HemoScreen" about.

feedback    direct    safety    36m    external    performance    hemoscreen    inefficiencies    containing    pol    visco    cytometry    microfluidic    24    reducing    market    time    poc    imaging    spread    85    hydrodynamic    waiting    usa    point    errors    trials    families    reduce    waiver    improvement    sites    requiring    gold    series    relies    employees    full    standard    patented    500    least    lab    conduct    ultimately    certification    analyser    disposable    glucose    72    cartridges    treatment    portable    50    headcount    hours    run    medical    classification    elastic    office    accordance    flow    revolutionize    calibration    introduction    minimizing    true    labs    blood    purchasing    8kg    oncology    characterization    uses    hematology    min    filed    revenues    sweden    fda    vision    launch    care    diagnostics    transcription    industrialization    instead    outcomes    cell    2020    preliminary    forecasts    tests    physicians    2022    designed    device    thousands    pixcell    operated    belgium    efficient    cutting    maintenance    physician    patient    clia    uk    patent    first    affordable    segments    chip    neonatal    trial   

Project "HemoScreen" data sheet

The following table provides information about the project.

Coordinator
PIXCELL MEDICAL TECHNOLOGIES LTD 

Organization address
address: 6 HAYEZIRA ST
city: YOKNEAM ILIT
postcode: 2069202
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 3˙556˙337 €
 EC max contribution 2˙489˙436 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PIXCELL MEDICAL TECHNOLOGIES LTD IL (YOKNEAM ILIT) coordinator 2˙489˙436.00

Map

 Project objective

HemoScreen is the first true point-of-care hematology analyser: a portable (8kg) and affordable (€4,500) device that can be operated by any medical personnel (no maintenance or calibration). The analyser uses low-cost (€8) disposable cartridges containing a high performance microfluidic chip. The phase 1 market study identified three priority segments for market introduction: physician office labs (POL), oncology and neonatal. In all 3 segments, HemoScreen can reduce the cost of the blood test by at least 50% as physicians can run the test with their own equipment instead of purchasing it from an external lab. More importantly, physicians can get immediate (9 min) results instead of waiting for 24-72 hours, cutting operational inefficiencies, reducing medical transcription errors, improving patient safety, minimizing the time to adequate treatment and ultimately, improving patient outcomes. HemoScreen relies on direct cell characterization based on imaging, the gold standard for cell classification, and a patented visco-elastic focusing method, which is more robust and efficient than hydrodynamic focusing (used in flow cytometry). The technology has already generated 7 patent families and 3 more are expected to be filed during this project. The project will conduct a series of trials involving over 4,000 blood tests over 5 trial sites spread between Sweden, Belgium, UK and USA. The trial results will be used for product improvement, industrialization and certification. Based on preliminary feedback from the FDA, the HemoScreen is the first true hematology POC analyser designed in accordance with CLIA waiver requirements, enabling thousands of physicians to run their own blood tests without requiring any lab certification. PixCell’s vision is to make cell-based diagnostics as simple as a glucose test and revolutionize POC diagnostics. Following a full market launch in 2020, PixCell medical forecasts revenues of €36M and headcount of 85 employees by 2022.

 Deliverables

List of deliverables.
Project website Websites, patent fillings, videos etc. 2020-01-16 15:53:22

Take a look to the deliverables list in detail:  detailed list of HemoScreen deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Anders Larsson
Hämatologi, ett laboratorieområde som kanske står inför stora förändringar
published pages: , ISSN: 1101-2013, DOI:
Nordisk Forening for Klinisk Kemi 2020-01-16
2019 Anders Larsson, Lena Carlsson, Bo Karlsson, Miklos Lipcsey
Rapid testing of red blood cell parameters in primary care patients using HemoScreenâ„¢ point of care instrument
published pages: , ISSN: 1471-2296, DOI: 10.1186/s12875-019-0971-2
BMC Family Practice 20/1 2020-01-16
2018 Anders Larsson, David Smekal, Miklos Lipcsey
Rapid testing of red blood cells, white blood cells and platelets in intensive care patients using the HemoScreenâ„¢ point-of-care analyzer
published pages: 1-4, ISSN: 0953-7104, DOI: 10.1080/09537104.2018.1557619
Platelets 2020-01-16
2018 Miklos Lipcsey, Johanna Helmersson-Karlqvist, Anders Larsson
Point of Care Testing of Red Blood Cells and Platelets in Intensive Care Patients Using HemoScreen
published pages: , ISSN: , DOI:
2020-01-16
2018 Miklos Lipcsey, Johanna Helmersson-Karlqvist, Anders Larsson
Rapid testing of red blood cells and platelets in intensive care patients using HemoScreenâ„¢ point of care instrument
published pages: , ISSN: , DOI:
2020-01-16

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEMOSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEMOSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

Cortx (2019)

Intelligent debt recovery platform.

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More